The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart Failure: The PRECISE Trial
Abstract
Background Carvedilol has improved the symptomatic status of patients with moderate to severe heart failure in single-center studies, but its clinical effects have not been evaluated in large, multicenter trials. Methods and Results We enrolled 278 patients with moderate to severe heart failure (6-minute walk distance, 150 to 450 m) and a left ventricular ejection fraction ≤0.35 at 31 centers. After an open-label, run-in period, each patient was randomly assigned (double-blind) to either placebo (n=145) or carvedilol (n=133; target dose, 25 to 50 mg BID) for 6 months, while background therapy with digoxin, diuretics, and an ACE inhibitor remained constant. Compared with placebo, patients in the carvedilol group had a greater frequency of symptomatic improvement and lower risk of clinical deterioration, as evaluated by changes in the NYHA functional class (P=.014) or by a global assessment of progress judged either by the patient (P=.002) or by the physician (P<.001). In addition, treatment with carvedilol was associated with a significant increase in ejection fraction (P<.001) and a significant decrease in the combined risk of morbidity and mortality (P=.029). In contrast, carvedilol therapy had little effect on indirect measures of patient benefit, including changes in exercise tolerance or quality-of-life scores. The effects of the drug were similar in patients with ischemic heart disease or idiopathic dilated cardiomyopathy as the cause of heart failure. Conclusions These findings indicate that, in addition to its favorable effects on survival, carvedilol produces important clinical benefits in patients with moderate to severe heart failure treated with digoxin, diuretics, and an ACE inhibitor. (Circulation. 1996;94:2793-2799.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649
Self-citationThe 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure.
Guyatt, G. H., Sullivan, M. J., Thompson, P. J., Fallen, E. L., Pugsley, S. O., Taylor, D. W., & Berman, L. (1985) · Europe PMC (PubMed Central) · Cited by 2,401
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
Waagstein, F., Hjalmarson, A., Swedberg, K., Bristow, M. R., Gilbert, E. M., Camerini, F., Fowler, M. B., Silver, M. A., Johnson, M. R., & Goss, F. G. (1993) · The Lancet · doi:10.1016/0140-6736(93)92930-r · Cited by 1,234
Patients' self-assessment of their congestive heart failure
Ts, R. (1987) · Medical Entomology and Zoology · Cited by 1,020
Adrenergic effects on the biology of the adult mammalian cardiocyte.
Mann, D. L., Kent, R. L., Parsons, B., & Cooper, G. (1992) · Circulation · doi:10.1161/01.cir.85.2.790 · Cited by 866
Packer, M., Gheorghiade, M., Young, J. B., Costantini, P. J., Adams, K. F., Cody, R. J., Smith, L. K., Van Voorhees, L., Gourley, L. A., & Jolly, M. K. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307013290101 · Cited by 827
Self-citation(1993) · New England Journal of Medicine · doi:10.1056/nejm199312093292417 · Cited by 639
DiBianco, R., Shabetai, R., Kostuk, W., Moran, J., Schlant, R. C., & Wright, R. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903163201101 · Cited by 550
Yue, T. L., Cheng, H. Y., Lysko, P. G., McKenna, P. J., Feuerstein, R., Gu, J. L., Lysko, K. A., Davis, L. L., & Feuerstein, G. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10363-7 · Cited by 485
Cerqueira, M. D., Verani, M. S., Schwaiger, M., Heo, J., & Iskandrian, A. S. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90424-3 · Cited by 464
Engelmeier, R. S., O'Connell, J. B., Walsh, R., Rad, N., Scanlon, P. J., & Gunnar, R. M. (1985) · Circulation · doi:10.1161/01.cir.72.3.536 · Cited by 439
DOUBLE-BLIND COMPARISON OF CAPTOPRIL ALONE AGAINST FRUSEMIDE PLUS AMILORIDE IN MILD HEART FAILURE
Richardson, A., Scriven, A. J., Poole-Wilson, P. A., Bayliss, J., Parameshwar, J., & Sutton, G. C. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91074-9 · Cited by 433
Krum, H., Sackner-Bernstein, J. D., Goldsmith, R. L., Kukin, M. L., Schwartz, B., Penn, J., Medina, N., Yushak, M., Horn, E., Katz, S. D., et al. (1995) · Circulation · doi:10.1161/01.cir.92.6.1499 · Cited by 374
Self-citationOlsen, S. L., Gilbert, E. M., Renlund, D. G., Taylor, D. O., Yanowitz, F. D., & Bristow, M. R. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00012-s · Cited by 373
Elkayam, U., Amin, J., Mehra, A., Vasquez, J., Weber, L., & Rahimtoola, S. H. (1990) · Circulation · doi:10.1161/01.cir.82.6.1954 · Cited by 343
Metra, M., Nardi, M., Giubbini, R., & Cas, L. D. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90174-0 · Cited by 320
Dulin, B., & Abraham, W. T. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.01.003 · Cited by 311
Eichhorn, E. J., Heesch, C. M., Barnett, J. H., Alvarez, L. G., Fass, S. M., Grayburn, P. A., Hatfield, B. A., Marcoux, L. G., & Malloy, C. R. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90114-7 · Cited by 306
Bristow, M. R., O'Connell, J. B., Gilbert, E. M., French, W. J., Leatherman, G., Kantrowitz, N. E., Orie, J., Smucker, M. L., Marshall, G., & Kelly, P. (1994) · Circulation · doi:10.1161/01.cir.89.4.1632 · Cited by 272
Self-citationBristow, M. R., Anderson, F. L., Port, J. D., Skerl, L., Hershberger, R. E., Larrabee, P., O'Connell, J. B., Renlund, D. G., Volkman, K., & Murray, J. (1991) · Circulation · doi:10.1161/01.cir.84.3.1024 · Cited by 252
Woodley, S. L., Gilbert, E. M., Anderson, J. L., O'Connell, J. B., Deitchman, D., Yanowitz, F. G., Mealey, P. C., Volkman, K., Renlund, D. G., & Menlove, R. (1991) · Circulation · doi:10.1161/01.cir.84.6.2426 · Cited by 223
The pharmacology of carvedilol
Ruffolo, R. R., Gellai, M., Hieble, J. P., Willette, R. N., & Nichols, A. J. (1990) · European Journal of Clinical Pharmacology · doi:10.1007/bf01409471 · Cited by 209
Fisher, M. L., Gottlieb, S. S., Plotnick, G. D., Greenberg, N. L., Patten, R. D., Bennett, S. K., & Hamilton, B. P. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90641-6 · Cited by 196
Self-citationOral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy
Currie, P. J., Kelly, M. J., Mckenzie, A., Harper, R. W., Lim, Y. L., Federman, J., Anderson, S. T., & Pitt, A. (1984) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(84)80449-0 · Cited by 163
Wisenbaugh, T. W., Katz, I. J., Davis, J., Essop, R., Skoularigis, J. S., Middlemost, S. J., Röthlisberger, C., Skudicky, D., & Sareli, P. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90230-x · Cited by 144
Yates, J. C., Beamish, R. E., & Dhalla, N. S. (1981) · American Heart Journal · doi:10.1016/s0002-8703(81)80012-9 · Cited by 130
Gilbert, E. M., Olsen, S. L., Renlund, D. G., & Bristow, M. R. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90083-o · Cited by 109
Attenuation of exercise conditioning by beta-adrenergic blockade.
Sable, D. L., Brammell, H. L., Sheehan, M. W., Nies, A. S., Gerber, J. G., & Horwitz, L. D. (1982) · Circulation · doi:10.1161/01.cir.65.4.679 · Cited by 102
Packer, M. (1987) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(87)80400-x · Cited by 85
Self-citationBril, A., Mark, S., DiMartino, M. J., et al. (1992) · Cardiovascular Research · doi:10.1093/cvr/26.5.518 · Cited by 79
Beta-blockers in heart failure: Promising or proved?
Doughty, R. N., MacMahon, S. W., & Sharpe, N. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90773-0 · Cited by 69
Parker, J. O. (1993) · International Journal of Cardiology · doi:10.1016/0167-5273(93)90004-z · Cited by 54
Attenuation of exercise conditioning by low dose beta-adrenergic receptor blockade
Marsh, R. C., Hiatt, W. R., Brammell, H. L., & Horwitz, L. D. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80284-8 · Cited by 44
Wilmore, J. H., Ewy, G. A., Freund, B. J., Hartzell, A. A., Jilka, S. M., Joyner, M. J., Todd, C. A., Kinzer, S. M., & PEPIN, E. B. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)91071-9 · Cited by 39
The placebo effect in heart failure
Packer, M. (1990) · American Heart Journal · doi:10.1016/0002-8703(90)90062-3 · Cited by 35
Self-citationGUNDERSEN, T., Swedberg, K. B., Amtorp, O., Remes, J., & NILSSON, B. (1994) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060449 · Cited by 30
Sparrow, J., Parameshwar, J. K., & Poole-Wilson, P. A. (1994) · Heart · doi:10.1136/hrt.71.4.391 · Cited by 24
Gullestad, L. L., Birkeland, K. I., Nordby, G., Larsen, S., & KJEKSHUS, J. K. (1991) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1991.tb03882.x · Cited by 20
Cited by
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
Cardiac Resynchronization in Chronic Heart Failure
Abraham, W. T., Fisher, W. G., Smith, A. L., Delurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Packer, M., Clavell, A. L., Hayes, D. L., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013168 · Cited by 4,648
Self-citationACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,154
2005 WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,720
Metadata
- Authors
- Packer, M., Colucci, W. S., Sackner-Bernstein, J. D., Liang, C.-S., Goldscher, D. A., Freeman, I., Kukin, M. L., Kinhal, V., Udelson, J. E., Klapholz, M., Gottlieb, S. S., Pearle, D., Cody, R. J., Gregory, J. J., Kantrowitz, N. E., LeJemtel, T. H., Young, S. T., Lukas, M. A., & Shusterman, N. H.
- Venue
- Circulation
- Published
- 1996-12
- Volume
- 94
- Issue
- 11
- Pages
- 2793-2799
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2088138316
- Cited by
- 613
- References
- 40
- FWCI
- 34.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.